The bill amends sections 28-405 and 28-416 of the Revised Statutes Cumulative Supplement, 2024, to update the schedules of controlled substances under the Uniform Controlled Substances Act. It introduces numerous new substances, particularly under Schedule I, including various opiates and synthetic opioids such as Meta-Fluorofentanyl and Para-Methoxyfuranyl fentanyl, in response to the rising concerns over synthetic opioids. The bill also makes specific deletions and modifications, such as replacing "shall mean" with "means" in the definition of peyote and clarifying that psilocybin does not include FDA-approved pharmaceutical compositions. Additionally, it updates the classifications of synthetic substances, including cannabinoids and psychoactive compounds, while excluding FDA-approved cannabidiol from these classifications.

Furthermore, the bill introduces new penalties for individuals aged eighteen years or younger convicted of drug offenses, with varying sanctions based on the number of offenses related to motor vehicle licenses. For first offenses, the court may impound the license for thirty days and require drug education classes, with increasing penalties for subsequent offenses. For those without a license, similar prohibitions on obtaining a license are established. The bill also emphasizes treatment and counseling for drug-related offenses and mandates that a copy of the court's conviction be sent to the Director of Motor Vehicles if a license is impounded. Overall, the bill aims to enhance the regulatory framework surrounding controlled substances and improve public health and safety.

Statutes affected:
Introduced: 28-405, 28-416
Final Reading: 28-405, 28-416
Slip Law: 28-405, 28-416